Rejected from Bioresource Technology? The 7 Best Journals to Submit Next

Source: Clarivate 2026 JCR release, Elsevier and ScienceDirect journal pages and guides for authors (accessed June 2026). APCs are list prices excluding tax and may be reduced at submission.

1. Bioresource Technology Reports. This is the in-house Elsevier sister title and the most natural landing spot for technically sound work that did not clear the flagship's novelty bar. It is fully gold open access, so factor the APC into the decision, but the topical fit is essentially identical, which removes the scope-mismatch risk that sinks cross-journal moves.

2. Biomass and Bioenergy. If your work is genuinely about converting biomass into energy or materials, this is the cleanest specialist alternative. It rewards papers that link biomass composition or process to actual bioenergy generation and weighs the environmental and economic side seriously.

3. Fuel. Strong for biofuel and biochar work that connects to combustion, emissions, or operational performance. Fuel increasingly desk-rejects papers that stop at characterization, so it fits best when your downstream fuel behavior is part of the story.

4. Renewable Energy. A good home when the real contribution is energy-system consequence rather than bioprocess detail. Its scope screen is explicit: a paper has to actually measure the energy generated, not just describe a material or process.

5. Industrial Crops and Products. If your manuscript is really about bio-based products, extractives, or valorization of agricultural and forestry residues into materials, this venue frames that contribution well and carries a lower APC than most peers on this list.

6. Waste Management. The better fit when the manuscript is fundamentally a waste-systems question, organic waste treatment, resource recovery, or anaerobic digestion at a systems level, rather than a bioconversion mechanism.

7. Chemical Engineering Journal. Reach for this only when the core advance is reaction engineering, separations, or process chemistry with broad applicability. The IF (~13.2) is the highest on this list and the bar is correspondingly high, so it suits work where the engineering, not the bioresource, is the protagonist.

Elsevier runs the Article Transfer Service (ATS), and a rejecting Bioresource Technology editor (working in the journal's Editorial Manager portal at Editorial Manager submission portal) can offer a one-click transfer that carries your manuscript files, and often the reviewer reports, to a more suitable journal. The matching uses editor recommendations plus algorithms that weigh topic, citation patterns, and acceptance rates. Over 2,300 Elsevier journals participate.

You can accept, decline all suggestions, or ignore the offer and submit manually. A transfer offer is a routing suggestion, not a quality endorsement, so treat the destination as you would any other target.

Practical ladder by rejection reason:

• Desk-rejected for scope (agronomy, standalone enzymes, combustion-in-engines, materials with a thin bioresource wrapper)? Do not cascade down the same family unchanged. The scope problem follows the paper. Pick the journal whose scope actually matches the work: Fuel, Renewable Energy, Waste Management, Industrial Crops and Products, or Chemical Engineering Journal.

• Rejected for incremental novelty but sound science? This is the classic transfer or step-down case.

Bioresource Technology Reports or Biomass and Bioenergy is the next tier. Accept an ATS offer here if the suggested journal fits.

• Rejected after review for a missing mass or energy balance, weak controls, or thin scale-up logic? Fix it before resubmitting anywhere. Every serious bioprocess venue will raise the same point. Carry the revised analysis into the transfer or the manual resubmission.

Four recurring rejection-letter patterns are especially useful for routing a Bioresource Technology manuscript. Each is journal-specific and testable against your own decision letter and manuscript, which is what makes the pattern worth checking before you resubmit anywhere.

The missing mass or energy balance. Across our Bioresource Technology pre-submission reviews, the single most common reviewer trigger is a yield or productivity claim with no accounting framework behind it. A manuscript reports "85 percent glucose yield" or "30 percent higher methane production" but never states substrate loading, energy input, or net energy relative to a conventional baseline.

Bioresource Technology publishes work meant to inform industrial bioprocess development, so reviewers expect a mass balance or at least a defensible energy balance that lets them judge whether the number is industrially meaningful. Add the balance and a one-line techno-economic argument, and a borderline paper often clears review. Without it, the result reads as a lab curiosity.

This is testable: look at your Results and ask whether a reader could reconstruct the inputs and outputs from your figures and tables.

Lab-only process data presented as a scalable advance. A second recurring pattern in the Bioresource Technology manuscripts we review is process data collected at flask or bench scale, framed in the abstract as a scalable solution, with no discussion of mass transfer, mixing, heat removal, or substrate cost at realistic loading. The editorial question at this journal is not "does it work in a 250 mL flask?"

but "could this work at a scale that matters?" Reviewers consistently flag the gap between the claim and the supporting process data. The fix is a paragraph that honestly addresses what changes at scale, or a reframing of the contribution as a mechanistic finding rather than a deployable process.

Insufficient characterization and weak controls. We see manuscripts where the central conversion or treatment claim rests on a single condition with no proper controls, no replication, and statistical analysis that does not match the experimental design. A pretreatment that "improves" digestibility needs an untreated control under identical conditions and enough replicates to support the effect size.

Bioresource Technology editors specifically screen for under-controlled studies early, and reviewers reject when the characterization cannot distinguish the reported effect from variability. Check that every headline claim has a matched control and a statistical test appropriate to your data structure.

Scope drift into chemistry, microbiology, or agronomy. The fourth pattern is a paper that is really environmental chemistry, microbial ecology, or crop agronomy wearing a bioresource label. The journal explicitly excludes crop cultivation and breeding, standalone enzyme studies, plant extracts, and engine combustion performance. When the manuscript's true center of gravity is one of those, the desk filter removes it fast, regardless of quality.

Read your own abstract and ask: is biomass conversion, bioprocessing, or resource recovery the actual protagonist, or a wrapper around a different field's question? If it is a wrapper, the right move is a different journal, not a resubmission.

Don't just resubmit the same file down the ladder. The fastest way to collect a second rejection is to send an unrevised manuscript to a journal that screens for the same thing Bioresource Technology did, and some manuscripts need real work, not a faster next submission. A desk rejection for scope is a routing problem you can fix by choosing the right journal and reformatting to its template.

A post-review rejection for a missing balance, weak controls, or thin scale-up logic is a substance problem, and the same reviewers' concerns will reappear at any serious venue. Be honest about which one you got.

Two cases call for real work before resubmitting, not a faster next submission. First, if reviewers questioned whether the result is industrially meaningful, the manuscript needs the mass or energy balance and the scale-up paragraph it was missing. Second, if the controls or statistics were challenged, new analysis (and sometimes new experiments) is the only fix. Appealing is rarely worth it: a scope or novelty rejection is an editorial judgment, not a factual error, and the appeal queue is slower than a clean resubmission to a better-fit journal.